Site Editors

Alexander Drilon, MD

Gregory J. Riely, MD, PhD

ESMO 2021: NTRK Fusion and KRAS Variation in Colorectal and Lung Cancers

ESMO 2021: Updated Analysis of Entrectinib in Advanced NTRK Fusion–Positive Solid Tumors

ESMO 2021: Dutch Study Focuses on NTRK Fusions as Potential Prognostic Biomarker

Rare Case of Recurrent Secretory Carcinoma of the Breast With NTRK3 Gene Fusion

Head and Neck Cancer in Chinese Patients: Focus on NTRK Aberrations

Novel Gene Fusion Partners in Sarcomas: Focus on NTRK for Targeted Therapy

NTRK Gene Fusion Analysis: Real-World Database of Patients With Cancer

Creative Treatment Approach to Advanced Salivary Gland Cancer With ETV6-NTRK3 Fusion: Case Study

Reassessing NTRK Testing in Patients With Bone Tumors

NTRK Gene Fusion Testing and Treatment Modifications: Survey of Medical Oncologists

Closer Look at NTRK Gene Fusions in Chinese Patients With Colorectal Cancer

Larotrectinib in TRK Fusion–Positive Cancers: Long-Term Follow-up

NTRK Gene Fusion in Middle Eastern Patients With Papillary Thyroid Cancer

Patterns of PD-L1 Expression in NSCLC Harboring Driver Oncogene Mutations Including NTRK Fusions

Positivity and Translocations of FGFR2 and NTRK1 in Intrahepatic Cholangiocarcinoma

UK Genomes Project: Are NTRK Gene Fusions Actionable Biomarkers?

Efficacy of Screening Methods for NTRK Gene Fusions in Solid Tumors

JNCCN Spotlights

Resources

For Cancer Care

ASCO: COVID-19 Medical Resources

NTRKers

JNCCN: How To Manage Cancer Care During COVID-19 Pandemic

The ASCO Post Video Roundtable: Updates in Lung Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.